ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$3.90
+0.29 (+8.03%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+356.2% upside
Low Target
$13.99
Average Target
$17.79
High Target
$22.90
Current Price
$3.90
Current
$3.90
$3.90
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Scenario Analysis
Bear Case
$13.99
258.7%
Low target
Base Case
$17.79
+356.2%
Avg target
Bull Case
$22.90
+487.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.60
-40.9% from high
52-Week Low
$2.10
+85.7% from low
50-Day SMA
$4.59
-15.0% vs SMA
200-Day SMA
$4.53
-13.9% vs SMA
RSI (14)
66.9
Neutral
Target vs 52W High
$17.79
+169.5% vs high
Next Earnings Report
Nov 11, 2026
Today
EPS Est: $-0.17
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals